Cargando…
Oxytocin as a treatment for high-risk psychosis or early stages of psychosis: a mini review
Individuals at clinical high risk for psychosis (CHR-P) present as help-seeking individuals with social deficits as well as cognitive and functional impairment and have a 23–36% risk of transition to first-episode psychosis. The therapeutic role of intranasal oxytocin (ΟΤ) in psychiatric disorders h...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470639/ https://www.ncbi.nlm.nih.gov/pubmed/37663608 http://dx.doi.org/10.3389/fpsyt.2023.1232776 |